.

Dr Graham Leask

 

Economics and Strategy Group

Graham Leask

Role: Economics & Strategy Business Partnership and Community Engagement Convenor
Position: Lecturer 
Phone: +44(0)121 204 3150 Email: g.leask@aston.ac.uk Room: SW1020B

  • Ph D, Cranfield University, 2005. Subject: “Strategic Groups and Competitive Groups in the UK Pharmaceutical Industry”. Department:  Industrial Economics/Strategic Management
  • MBA, Aston University, 1984.
  • MSc, Imperial College, University of London, 1979. Subject: Applied Temperate and Tropical Entomology
  • BSc, University of Reading, 1978. Subject: Zoology and Physiology

Academic

  • Lecturer, Aston Business School. (2000 - Present) 

 Professional

  • Managing Director, Ashbourne Pharmaceuticals. (1999)
  • Head of Pharmaceutical Business, Roche, UK. (1997 - 1999)
  • Strategic Planning Director, Astra Corporate, Sodertalje, Sweden. (1995 - 1997)
  • Cardiovascular, CNS & Pain Control Div Astra Pharmaceuticals. (1991 - 1995)
  • BS1131: Foundations of Management
  • BS3352: Value Based Strategy
  • BS3357: Entrepreneurial Management
 
  • Competitive strategy in industry dynamics in the pharmaceutical and healthcare industries
  • Measuring the value of strategic actions
  • Measurement and improvement of sales and marketing activitites leading to increased productivity
  • Merger and acquisition in the pharmaceutical and healthcare industries
  • Evolution of market positions

  • Leask, Graham, "An Econometric Analysis of Ecosystem Services of Habitat Improvement Schemes," Sponsored by NERC / Middlemarch Environmental Ltd, £ (GBP) 80,110.00.  

Research in Progress

  • Tapinos, E., Leask, G., Brown, M. (2014). The impact of environmental perceptions on corporate strategy, before and after the UK recession.
  • Cruickshank, S.L., Leask,G., Fermor, P. (2014) The systematic review of floral indicator species survey methodology and units in the UK. Ecological Indicators. (Revise & Resubmit)

Refereed Journal Articles

  • Leask, G. (2007). Making sense of industry dynamics: Is there still value in strategic group research?.Journal of Medical Marketing, 7(3), 189-203.
  • Leask, G., Parker, D. (2007). Strategic groups, competitive groups and performance within the UK pharmaceutical industry: Improving our understanding of competitive process. Strategic Management Journal, 28(7), 723-745.
  • Leask, G., Parker, D. (2006). Strategic group theory: review, examination and application in the UK pharmaceutical  industry. Journal of Management Development, 25(4), 386-408.
  • Leask, G., Parnell, J. (2005). Integrating strategic groups and the resource-based perspective: understanding the competitive process. European Management Journal, 23(4), 458-470.
  • Leask, G. (2005). Use of strategy frameworks to analyze competitive dynamics in the pharmaceutical industry. Journal of Medical Marketing, 5(3), 209-218.
  • Leask, G., Parker, D. (2004). An application of strategic group theory to the UK pharmaceuticals industry. European Business Journal, 16(1), 01-Sep.

Book Chapters

  • Leask, G. (2010). Strategic groups, cognitive groups and environmental change in the UK pharmaceutical industry. Managerial cognition and strategic management: rethinking internationalization strategies. New York: Nova Science Publishers.

Industry Journal Articles

  • Leask, G. (2009). Keeping in step: Measuring the effect of promotional investments ensures strategies stay in line with the market. Pharmaceutical Marketing. 47-48.
  • Leask,G. (2008) Start afresh. Pharmaceutical Marketing Europe. November/December.
  • Leask,G. (2008) Get more out. Pharmaceutical Marketing Europe. May/June.
  • Leask, G. (2007) Stop wasting marketing spend. Learn to drive sales. The Grocer. September 1st.
    Leask,G. (2007) Handle with care. Pharmaceutical Marketing. June.
  • Leask,G. (2007) Isolating factors. Pharmaceutical Marketing. March.
  • Leask,G. (2006) Chaos theory. Pharmaceutical Marketing. September.
  •  Leask,G. (2005) Improving returns on promotion: Europe a myriad of possibilities  . Pharmaceutical Marketing Europe. September.
  • Leask,G. (2004) Getting more out. Pharmaceutical Times. September.
  • Leask,G. (2004) Vicious circle. Pharmaceutical Marketing. June.
  • Leask,G. (2004) Rules of engagement. Pharmaceutical Times. May.
  • Leask,G. (2003) Go your own way. Pharmaceutical Marketing. September.
  • Leask,G. (2003) Target practice. Understanding the local influence network. Pharmaceutical Marketing. May.
  • Leask,G. (2003) Market levers. Pharmaceutical Times. March.
  • Leask,G. (2003) Separating winners from losers. Pharmatimes. March.
  • Leask,G. (2002) Open Sesame Dispensing Doctors. Pharmaceutical Marketing. December.
  • Leask,G. (2002) Outperforming competitors. Pharmaceutical Times. November.

Working Papers

  • Leask, G (with Parker, D) Strategic group theory: Still a rich research vein or simply a worn out old seam?  RP0313 Aston Business School: Birmingham
  • Leask, G (with Parker, D) An application of strategic group theory to the UK pharmaceuticals industry  RP0314 Aston Business School: Birmingham
  • Leask, G Is there still value in strategic group research? RP0404 Aston Business School: Birmingham
  • Leask, G Strategic groups & the resource based view: Natural complements enhancing our understanding of the competitive process  RP0405 Aston Business School: Birmingham
  • Leask, G (with Parker, D) Strategic groups, competitive groups and performance within the UK pharmaceutical industry: Improving our understanding of the competitive process  RP0407 Aston Business School: Birmingham
  • Leask, G Use of strategy framework to analyse competitive dynamics in the Pharmaceutical industry  RP0508 Aston Business School: Birmingham
  • Leask, G Strategic groups, nationality and environmental change in the UK pharmaceutical industry  RP0525 Aston Business School: Birmingham
  • Leask, G Making sense of strategic choice: Strategic groups and the classification of strategy. RP0601
  • Leask, G Strategic groups, mergers and dynamics of change in the UK Pharmaceutical Industry 1993-2002. RP0610
  • Leask, G Is data structure accurately reflected in management research? A comparison of different clustering methods. RP0710
  • Leask, G (with Bissoondeeal R and Binner J ) Finding natural groups in data: an application to strategic group research. RP0714
  • Leask, G (with Scott, J. Irwin,D) Do strategic groups play a role in the SME financing process? RP0924

Published Intellectual Contributions

  • Leask, G. (2010). Strategic groups, cognitive groups and environmental change in the UK pharmaceutical industry. Managerial cognition and strategic management: rethinking internationalization strategies. New York: Nova Science Publishers
  • Leask, G., Parker, D. (2007). Strategic groups, competitive groups and performance within the UK pharmaceutical industry: Improving our understanding of competitive process. Strategic Management Journal, 28(7), 723-745.
  • Leask, G., Parker, D. (2006). Strategic group theory: review, examination and application in the UK pharmaceutical industry. Journal of Management Development, 25(4), 386-408.
  • Leask, G., Parnell, J. (2005). Integrating strategic groups and the resource-based perspective: understanding the competitive process. European Management Journal, 23(4), 458-470.
  • Leask, G. (2005). Use of strategy frameworks to analyze competitive dynamics in the pharmaceutical industry. Journal of Medical Marketing, 5(3), 209-218.
  • Leask, G., Parker, D. (2004). An application of strategic group theory to the UK pharmaceuticals industry. European Business Journal, 16(1), 01-Sep.

Administrative Roles and Responsibilities

  • DBA Doctoral Programme Director, School. (September 2009 – August 2012)

Employable Graduates; Exploitable Research